Boston Scientific Corporation (NYSE:BSX) has announced the signing of a definitive agreement with European specialty pharmaceutical group, SERB’s affiliates SERB SAS and Stark International Lux S.A.R.L. The agreement is for the sale of Boston Scientific’s...
Boston Scientific (NYSE:BSX) has announced that the US FDA has approved the Ranger™ Drug-Coated Balloon. It is under development to treat patients having peripheral artery disease in the superficial femoral and proximal popliteal arteries. PAD affects 200 million...
